SEC Form 4 · accession 0001144204-18-051889
USANA HEALTH SCIENCES INC · USNA
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Gull Global Ltd
Director · 10% Owner
Period of report
Oct 1, 2018
Accepted (ET)
Oct 1, 2018 · 8:38 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000896264
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF2,F3 | Oct 1, 2018 | S | 22,395 | $119.66 | D | 9,993,219 | D | |
| Common StockF3,F4 | Oct 1, 2018 | S | 7,605 | $120.55 | D | 9,985,614 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1This sale was effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person.
- F2Weighted average price. Price range in multiple transactions was $119.44 to $120.40, inclusive.
- F3The reporting person undertakes to provide USANA Health Sciences, Inc., any security holder thereof or the staff of the Securities Exchange Commission information regarding the number of shares sold at each price within the ranges set forth.
- F4Weighted average price. Price range in multiple transactions was $120.44 to $120.68, inclusive